Activin and Inhibin

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor.Target:PBRin vitro: DAA1106 binding to PBR was significantly increased in widespread

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor.Target:PBRin vitro: DAA1106 binding to PBR was significantly increased in widespread

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor.Target:PBRin vitro: DAA1106 binding to PBR was significantly increased in widespread

DAA1106 is a potent and selective ligand for peripheral benzodiazepine receptor (PBR), as a potent and selective agonist at the peripheral benzodiazepine receptor.Target:PBRin vitro: DAA1106 binding to PBR was significantly increased in widespread

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.IC50 value:Target: thrombin Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory controls. Of

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.IC50 value:Target: thrombin Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory controls. Of

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.IC50 value:Target: thrombin Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory controls. Of

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.IC50 value:Target: thrombin Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory controls. Of

Dabigatran ethyl ester is an emerging oral anticoagulant which is a direct inhibitor of thrombin activity.IC50 value:Target: thrombin Dabigatran provides a stable anticoagulation effect without any need to perform periodical laboratory controls. Of

Dabigatran ethyl ester hydrochloride is a potent inhibitor of ribosyldihydronicotinamide dehydrogenase ( NQO2 ) with an IC 50 value of 0.8 μM and a thrombin inhibitor.In VitroThe K i of dabigatran (ethyl ester hydrochloride) toward NQO2 is 0.9 μM

Dabigatran ethyl ester hydrochloride is a potent inhibitor of ribosyldihydronicotinamide dehydrogenase ( NQO2 ) with an IC 50 value of 0.8 μM and a thrombin inhibitor.In VitroThe K i of dabigatran (ethyl ester hydrochloride) toward NQO2 is 0.9 μM

Dabigatran ethyl ester hydrochloride is a potent inhibitor of ribosyldihydronicotinamide dehydrogenase ( NQO2 ) with an IC 50 value of 0.8 μM and a thrombin inhibitor.In VitroThe K i of dabigatran (ethyl ester hydrochloride) toward NQO2 is 0.9 μM